Literature DB >> 20233718

sZIP, an alternative splice variant of ZIP, antagonizes transcription repression and growth inhibition by ZIP.

Wenhua Yu1, Ruifang Li, Bin Gui, Yongfeng Shang.   

Abstract

Recently, we reported a novel transcriptional repressor, ZIP (for zinc finger and G-patch domain-containing), which recruits the Mi-2/NuRD (nucleosome remodeling and deacetylase) complex and represses the expression of epidermal growth factor receptor (EGFR). In doing so, ZIP inhibits cell proliferation and suppresses breast carcinogenesis. Here, we report the cloning and the characterization of an alternatively spliced isoform of ZIP, sZIP. sZIP is an N-terminal truncated form of ZIP, lacking the zinc finger but retaining part of the G-patch domain and C-terminal coiled-coil domain of ZIP. We showed that sZIP could interact with the NuRD complex but lost its DNA-binding capacity. We demonstrated that sZIP antagonizes the transcription repression by ZIP by competing for the binding of the NuRD complex and that sZIP alleviates the growth inhibitory effect of ZIP on hepatocarcinoma cells through attenuating the transcriptional repression of EGFR. Our data provide a finely tuned mechanism for EGFR regulation and add another player for transcription repression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20233718      PMCID: PMC2863213          DOI: 10.1074/jbc.M110.107508

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  DLP, a novel Dim1 family protein implicated in pre-mRNA splicing and cell cycle progression.

Authors:  Xiaojing Sun; Hua Zhang; Dan Wang; Dalong Ma; Yan Shen; Yongfeng Shang
Journal:  J Biol Chem       Date:  2004-05-25       Impact factor: 5.157

Review 2.  Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: a review of chemotherapy.

Authors:  P J Barrett-Lee
Journal:  Endocr Relat Cancer       Date:  2005-07       Impact factor: 5.678

Review 3.  Epidermal growth factor receptor targeting in cancer.

Authors:  John Mendelsohn; Jose Baselga
Journal:  Semin Oncol       Date:  2006-08       Impact factor: 4.929

4.  Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines.

Authors:  Lorella Bonaccorsi; Daniele Nosi; Monica Muratori; Lucia Formigli; Gianni Forti; Elisabetta Baldi
Journal:  J Mol Endocrinol       Date:  2007-02       Impact factor: 5.098

Review 5.  Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response.

Authors:  Burkhard Brandt; Sönke Meyer-Staeckling; Hartmut Schmidt; Konstantin Agelopoulos; Horst Buerger
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

6.  Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation.

Authors:  Huijian Wu; Luyang Sun; Ying Zhang; Yupeng Chen; Bin Shi; Ruifang Li; Yan Wang; Jing Liang; Dongwei Fan; Ge Wu; Dan Wang; Shaosi Li; Yongfeng Shang
Journal:  J Biol Chem       Date:  2006-06-07       Impact factor: 5.157

7.  The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription.

Authors:  Hua Zhang; Luyang Sun; Jing Liang; Wenhua Yu; Ying Zhang; Yan Wang; Yupeng Chen; Ruifang Li; Xiaojing Sun; Yongfeng Shang
Journal:  EMBO J       Date:  2006-09-07       Impact factor: 11.598

8.  Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.

Authors:  Huijian Wu; Yupeng Chen; Jing Liang; Bin Shi; Ge Wu; Ying Zhang; Dan Wang; Ruifang Li; Xia Yi; Hua Zhang; Luyang Sun; Yongfeng Shang
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

9.  The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2beta and agonist-independent coupling with downstream signalling events.

Authors:  Jennifer L Gilmore; Richard M Gallo; David J Riese
Journal:  Biochem J       Date:  2006-05-15       Impact factor: 3.857

10.  EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).

Authors:  Lorella Bonaccorsi; Vinicio Carloni; Monica Muratori; Lucia Formigli; Sandra Zecchi; Gianni Forti; Elisabetta Baldi
Journal:  Int J Cancer       Date:  2004-10-20       Impact factor: 7.396

View more
  7 in total

Review 1.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

2.  Alternative splicing regulates Prdm1/Blimp-1 DNA binding activities and corepressor interactions.

Authors:  Marc A J Morgan; Arne W Mould; Li Li; Elizabeth J Robertson; Elizabeth K Bikoff
Journal:  Mol Cell Biol       Date:  2012-06-25       Impact factor: 4.272

3.  HIV-1 Vpr induces the degradation of ZIP and sZIP, adaptors of the NuRD chromatin remodeling complex, by hijacking DCAF1/VprBP.

Authors:  Claire Maudet; Adèle Sourisce; Loïc Dragin; Hichem Lahouassa; Jean-Christophe Rain; Serge Bouaziz; Bertha Cécilia Ramirez; Florence Margottin-Goguet
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

Review 4.  Regulation of DEAH/RHA helicases by G-patch proteins.

Authors:  Julien Robert-Paganin; Stéphane Réty; Nicolas Leulliot
Journal:  Biomed Res Int       Date:  2015-01-27       Impact factor: 3.411

5.  Loss of ZIP facilitates JAK2-STAT3 activation in tamoxifen-resistant breast cancer.

Authors:  Ning Zhu; Jing Zhang; Yuping Du; Xiaodong Qin; Ruidong Miao; Jing Nan; Xing Chen; Jingjie Sun; Rui Zhao; Xinxin Zhang; Lei Shi; Xin Li; Yuxi Lin; Wei Wei; Aihong Mao; Zhao Zhang; George R Stark; Yuxin Wang; Jinbo Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-12       Impact factor: 11.205

Review 6.  Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma.

Authors:  Olga Krivtsova; Anna Makarova; Natalia Lazarevich
Journal:  World J Hepatol       Date:  2018-10-27

Review 7.  Vpr and Its Cellular Interaction Partners: R We There Yet?

Authors:  Helena Fabryova; Klaus Strebel
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.